Xeris Biopharma Holdings, Inc

MAIA Biotechnology, Inc., based in Chicago, IL, is focused on developing innovative cancer therapies through its pipeline of products currently under clinical investigation. The company's research emphasizes telomere targeting immunotherapies, including their lead program, Ateganosine, and several second-generation initiatives. Committed to advancing cancer treatment, MAIA Biotechnology's efforts are grounded in a scientific approach, although the safety and effectiveness of its products have yet to be established. The company's dedicated management team and advisory board guide its mission to innovate within the oncology landscape. Generated from the website

AltaThera Pharmaceuticals, based in Chicago, IL, is a precision medicine company dedicated to enhancing patient care through innovative science and individualized treatment solutions for cardiovascular drug therapy. With a focus on addressing the global arrhythmia epidemic, AltaThera is committed to bridging the gap between scientific innovation and clinical decision-making. The company's flagship product, Sotalol IV, represents a new formulation of a trusted antiarrhythmic drug that aims to streamline patient care by converting inpatient procedures to outpatient settings, ultimately reducing hospital stays. By leveraging clinical data to optimize the use of existing medications, AltaThera strives to improve treatment outcomes for diverse patient populations. Generated from the website

Orphazyme is a biopharmaceutical company based in Chicago, IL that focuses on developing treatments for rare genetic diseases. With a commitment to innovative research and patient-centered care, Orphazyme strives to address unmet medical needs and improve the lives of individuals affected by these conditions. Generated from their business information